Intercept Pharmaceuticals Inc (ICPT) Return on Equity ROE from the third quarter 2023 to third quarter 2022 and annually, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intercept Pharmaceuticals inc   (NASDAQ: ICPT)

Intercept Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Intercept Pharmaceuticals Inc in the third quarter 2023?
Intercept Pharmaceuticals Inc recorded a cumulative net loss of $-62 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -82.24%.

Within the Major Pharmaceutical Preparations industry 258 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2023 from 30 to 3460.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Equity Change -33.28 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -62 209 207 222 206
Return On Equity (TTM) -82.24 % 248.75 % - - -
ICPT's Total Ranking # 3460 # 30 # 0 # 0 # 0
Equity (TTM) in Millions 72 68 67 93 108
Seq. Equity Change 6.36 % 0.54 % -27.82 % -13.56 % -
Seq. Net Income Change - - - - -

Back to ICPT Management Effectiveness >> ICPT's 5 Years Annual ROE >> Compare ICPT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 259
Sector # 584
Overall # 3460

Return On Equity Statistics
High Average Low
248.75 %
-328.64 %
-1973.1 %
(Jun 30 2023)   (Jun 30 2020)





ICPT Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 93 -184 -167 52 19
Y / Y Equity Change - - - 169.5 % 16.75 %
Net Income in Millions 222 -91 -275 -345 -309
Y / Y Net Income Change - - - - -
Return On Equity 238.31 % - - -668.56 % -1616.53 %

Back to ICPT Management Effectiveness >> ICPT's 5 Years Annual ROE >> Compare ICPT ROE to its Competitors




Annual Roe Comment
In 2022 ROE fell to 238.31 %, despite net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ICPT's' Return on Equity at Yahoo Finance
ICPT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ICPT's Competitors
Subscribers only: Roe for Intercept Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for ICPT's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE

Date modified: 2026-09-08T15:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.